Dr. James J. Harding is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College. He specializes in Gastrointestinal Cancer with a clinical and research focus on liver and biliary tract cancers.
Office
Memorial Sloan Kettering Cancer Center 1275 York Ave New York, NY 10065
Harding, J., Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Do-Youn Oh, Paul Severson, Betty Y Tam, Benjamin Garmezy, Mitesh J Borad, Shumei Kato, Cheng Quah, James ...> ;Cancer Research Communications. 2024 Apr 11
Harding, J., Sarah M McIntyre, William A Preston, Henry Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel, Michael E Lidsky, Peter J Allen, Michael A Morse, Wei Chen, ...> ;JCO Precision Oncology. 2024 Feb 1
Chami, P., Diab, Y., Jarnagin, W., Hajj, J., El Homsi, M., Khalil, D., Azhari, H., Abou-Alfa, G., Harding, J., Ma, J., Reyngold, M., Crane, C., Hajj, C.> ;International Journal of Molecular Sciences. 2023 Nov 26
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, Lynn E Nooijen, Andrea Cercek, Michael I D'Angelica, Marjolein Y V Homs, Alice C Wei, Vinod P Balachandran, Jef...> ;Annals of Surgical Oncology. 2024 Feb 1
Sara Velayati, Ahmed Elsakka, Ken Zhao, Joseph P Erinjeri, Brett Marinelli, Mohamed Soliman, Olivier Chevallier, Etay Ziv, Lynn A Brody, Constantinos T Sofocleous, Ste...> ;Current Oncology. 2023 Oct 18
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, Lynn E Nooijen, Andrea Cercek, Michael I D'Angelica, Marjolein Y V Homs, Alice C Wei, Vinod P Balachandran, Jef...> ;Annals of Surgical Oncology. 2024 Jan 1
Darren Cowzer, Jessica B White, Joanne F Chou, Pin-Jung Chen, Tae-Hyung Kim, Danny N Khalil, Imane H El Dika, Katrina Columna, Amin Yaqubie, Joseph S Light, Jinru Shia...> ;JCO Precision Oncology. 2023 Sep 1
Harding, J., Jasmine H Francis, William Foulsham, Julia Canestraro, James J Harding, Eli L Diamond, Alexander Drilon, David H Abramson> ;Ocular Oncology and Pathology. 2023 Aug 1
Kevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, Kenneth P Seier, Mithat Gönen, Carlie Sigel, Naaz Nasar, Andrea Cercek, James J Harding, Nancy E Kemeny, Louise ...> ;Cancer Medicine. 2023 Jun 1
Perla Chami, William Jarnagin, Ghassan K Abou-Alfa, James Harding, Neal Kim, Haibo Lin, Maria El Homsi, Christopher Crane, Carla Hajj> ;Cancers. 2023 Mar 14
James J Harding, Christiane Jungels, Jean-Pascal Machiels, David C Smith, Chris Walker, Tao Ji, Ping Jiang, Xin Li, Ekaterine Asatiani, Eric Van Cutsem, Ghassan K Abou...> ;Targeted Oncology. 2023 Mar 1
James J Harding, Sarina A Piha-Paul, Ronak H Shah, Jessica J Murphy, James M Cleary, Geoffrey I Shapiro, David I Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Shere...> ;Nature Communications. 2023 Feb 6
Enaksha Wickremsinhe, Antoniu Fantana, Erwin Berthier, Brook A Quist, Diego Lopez de Castilla, Charles Fix, Kahlil Chan, Jing Shi, Michael G Walker, Jennifer F Kherani...> ;The Journal of Applied Laboratory Medicine. 2023 May 4
Nicolas A Giraldo, Esther Drill, Baby A Satravada, Imane El Dika, A Rose Brannon, Josephine Dermawan, Abhinita Mohanty, Kerem Ozcan, Debyani Chakravarty, Ryma Benayed,...> ;Clinical Cancer Research. 2022 Dec 15
James J Harding, Ahmad Awada, Gael Roth, Thomas Decaens, Philippe Merle, Nuria Kotecki, Chantal Dreyer, Christelle Ansaldi, Madani Rachid, Soraya Mezouar, Agnes Menut,...> ;Liver Cancer. 2022 Jun 1
James J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, Cynthia Basu, Afshin Dowlati, Alison Forgie, Andrea T Hooper, Cris Kamperschroer, Steven I Max, Allison Moreau,...> ;Frontiers in Immunology. 2022 Jan 1
Dazhi Liu, Michael A Weintraub, Christine Garcia, Marcus D Goncalves, Ann Elizabeth Sisk, Alissa Casas, James J Harding, Stephen Harnicar, Alexander Drilon, Komal Jhav...> ;Cancer Medicine. 2022 Apr 1
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E Sanborn, Randy F Sweis, Patricia LoRusso, Misako...> ;Clinical Cancer Research. 2022 May 13
A phase II randomized placebo-controlled study investigating the combination of yiv-906 and sorafenib (SORA) in HBV (+) patients (Pts) with advanced hepatocellular car...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Nivolumab (NIVO) and drug eluting bead transarterial chemoembolization (deb-TACE): Preliminary results from a phase I study of patients (pts) with liver limited hepato...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
ADI-PEG 20 and FOLFOX6: A phase 1 study in pts (pts) with advanced hepatocellular carcinoma (HCC).
Treatment Options for Advanced HCC Patients Who Are Not Eligible for IO First LineMarch 14th, 2023
Puma Biotechnology Presents Interim Results from the Biliary Tract Cohort of Its Phase II SUMMIT Basket Trial of Neratinib at the ESMO World Congress on Gastrointestinal Cancer 2019July 3rd, 2019
Anti–TIM-3 Antibody Well Tolerated as Monotherapy and in Combination with Anti–PD-L1 AntibodyApril 10th, 2019